Skin Microbiome 2018 | Kisaco Research
Translating microbiome research into clinically & commercially viable cosmetics & therapeutics, revolutionizing dermatology.
Boston, USA
30-31 May, 2018
Download Agenda
The Audience
Register

Why Attend

The average consumer spends $5 a day on skincare, whilst using up to 515 synthetic chemicals daily to eradicate dermalogical concerns - how can this be good for skin? Introducing the Skin Microbiome Congress.

Following the mainstream focus on the gut microbiome and its role in health and disease, researchers and industry experts are now turning their attention towards the emerging relationship between the skin microbiome and healthy skin. This has the potential to revolutionise the beauty and personal care industry.

Join 100+ industry experts from multinational pharmaceutical, beauty and personal care companies, along with the independent skincare brands and innovative biotechs who are advancing the field.

Discover the potential of prebiotic, probiotic and postbiotic products being developed to protect and promote a healthy microbiome and ultimately combat dermatological conditions from acne and eczema to dandruff and skin allergies. Take advantage of: 

  • Effective Networking - Pre-schedule private meetings with any individual or company onsite using the online meeting scheduler application
  • Cutting Edge Research – Discover the latest advancement in therapeutic & cosmetic products containing live bacteria, bacterial extracts, or active ingredients to promote & protect the skins microbiome
  • Consumer Trends - Understand how consumers trends towards natural, organic products and active beauty are shaping the evolution of products adapted to the skin microbiome
  • Clinical Trials – Explore how to design an effective clinical trial & translate research into clinically & commercially viable therapeutics
  • Competitive Edge – Determine how to differentiate your product line & seize this market opportunity, gaining market share with scientifically backed products
  • Regulation – Understand the different paths to market & regulatory considerations necessary to launch a cosmetic or therapeutic product

With an increasing consumer trend towards natural products, what’s more natural than harnessing the bacteria on your skin? Don't miss your chance to understand the next generation of natural skincare products!

2
Full conference days
25+
Industry Speakers
100+
Beauty & pharma experts
15+
Dedicated networking hours

Who Will Be There

15%
Multinational Beauty & Personal Care Companies
15%
Multinational Pharmaceutical Companies
60%
Skincare Brands & Biotechnology Companies
5%
Formulators, Ingredients Suppliers & Packaging Manufacturers
5%
Sequencing Companies & Solution Providers

Multinational Beauty & Personal Care Companies

Multinational Pharmaceutical Companies

Skincare Brands & Biotechnology Companies

Formulators, Ingredients Suppliers & Packaging Manufacturers

Sequencing Companies & Solution Providers

The Speakers

 

Cécile Clavaud

Project Leader
Skin Microbiome Unit, L'oreal Research & Innovation

Cécile Clavaud

Project Leader
Skin Microbiome Unit, L'oreal Research & Innovation
 

Marie Drago

Founder
Gallinee

Marie Drago is a French Doctor in Pharmacy and a member of the French Society of Cosmetic Science, with over 15 years’ experience working for successful and innovative skincare brands. After discovering how a prebiotic and probiotic diet could improve the symptoms of the gluten intolerance that had been plaguing her life for years, Marie got a Eureka moment: What if we applied the same science to skin?

Marie Drago

Founder
Gallinee

Marie Drago is a French Doctor in Pharmacy and a member of the French Society of Cosmetic Science, with over 15 years’ experience working for successful and innovative skincare brands. After discovering how a prebiotic and probiotic diet could improve the symptoms of the gluten intolerance that had been plaguing her life for years, Marie got a Eureka moment: What if we applied the same science to skin?

 

David Tyrrell

Global Skincare Analyst
Mintel

David’s experience in skincare has spanned over 15 years. During his tenure at Kimberly-Clark he held positions in Corporate Research, New Product Development and Technology Scouting & Alliance Management. He has been active in identifying a variety of consumer and medical device technologies and products for in-licensing and led international research efforts in the biological characterization of naturally sourced skincare ingredients. David has a BS in Chemistry and a PhD in Biochemistry.

David Tyrrell

Global Skincare Analyst
Mintel

David’s experience in skincare has spanned over 15 years. During his tenure at Kimberly-Clark he held positions in Corporate Research, New Product Development and Technology Scouting & Alliance Management. He has been active in identifying a variety of consumer and medical device technologies and products for in-licensing and led international research efforts in the biological characterization of naturally sourced skincare ingredients. David has a BS in Chemistry and a PhD in Biochemistry.

 

Dirk Loeffert

CEO
Biomillenia

Dirk is co-founder of BIOMILLENIA and a senior executive of the Life Sciences industry with more than 20 years of experience in product development and commercialisation. After obtaining his Ph.D. in molecular genetics and immunology from the University of Cologne, Dirk joined QIAGEN where he was instrumental in building several new product portfolios at QIAGEN, such as QIAGENs enzyme and assay product portfolios. He represented in his former function at QIAGEN global product development as VP, Global Head of Product Development Life Sciences.

Dirk Loeffert

CEO
Biomillenia

Dirk is co-founder of BIOMILLENIA and a senior executive of the Life Sciences industry with more than 20 years of experience in product development and commercialisation. After obtaining his Ph.D. in molecular genetics and immunology from the University of Cologne, Dirk joined QIAGEN where he was instrumental in building several new product portfolios at QIAGEN, such as QIAGENs enzyme and assay product portfolios. He represented in his former function at QIAGEN global product development as VP, Global Head of Product Development Life Sciences.

 

Dr. Chris Callewaert

Post-doctoral researcher
Center for Microbial Ecology & Technology, Ghent University

Chris received his PhD from Ghent University in Belgium. He is now a postdoctoral research fellow in the Knight lab at the University of California, San Diego. He investigates body odor and the characteristics of the bacteria living in the armpits, skin, clothes, washing machines and homes. He is the first to undertake bacterial transplants to solve underarm body odour.

Dr. Chris Callewaert

Post-doctoral researcher
Center for Microbial Ecology & Technology, Ghent University

Chris received his PhD from Ghent University in Belgium. He is now a postdoctoral research fellow in the Knight lab at the University of California, San Diego. He investigates body odor and the characteristics of the bacteria living in the armpits, skin, clothes, washing machines and homes. He is the first to undertake bacterial transplants to solve underarm body odour.

 

Dr. Nick Monsul

Founder & Chairman
Quorum Innovations

Dr.

Dr. Nick Monsul

Founder & Chairman
Quorum Innovations

Dr.

 

Dr. Roshini Raj

Co-Founder
TULA

Dr. Roshini Raj is a board certified gastroenterologist and internist with a medical degree from New York University School of Medicine and an undergraduate degree from Harvard College.

She is an Associate Professor of Medicine at NYU School of Medicine, and an Attending Physician at NYU Langone Medical Center. Dr. Raj has a special interest in women’s health and cancer screening and has published several research articles on colon cancer screening.

Dr. Roshini Raj

Co-Founder
TULA

Dr. Roshini Raj is a board certified gastroenterologist and internist with a medical degree from New York University School of Medicine and an undergraduate degree from Harvard College.

She is an Associate Professor of Medicine at NYU School of Medicine, and an Attending Physician at NYU Langone Medical Center. Dr. Raj has a special interest in women’s health and cancer screening and has published several research articles on colon cancer screening.

 

Jason Harcup

Global Vice President Personal Care Research and Global Vice President Prestige Division R&D
Unilever

Dr. Jason Harcup is Global Vice President for Personal Care Research, responsible for Unilever’s worldwide research program across its €20 Billion Personal Care businesses in Skin Care and Cleansing, Hair and Scalp, Deodorants, Oral Care and also delivering to the Prestige Division. He has ultimate responsibility for several hundred mostly PhD level scientists located in 5 laboratories across the USA, Europe, India and China. He is located in Unilever’s UK research hub.

Jason Harcup

Global Vice President Personal Care Research and Global Vice President Prestige Division R&D
Unilever

Dr. Jason Harcup is Global Vice President for Personal Care Research, responsible for Unilever’s worldwide research program across its €20 Billion Personal Care businesses in Skin Care and Cleansing, Hair and Scalp, Deodorants, Oral Care and also delivering to the Prestige Division. He has ultimate responsibility for several hundred mostly PhD level scientists located in 5 laboratories across the USA, Europe, India and China. He is located in Unilever’s UK research hub.

 

Julia Oh

Assistant Professor
The Jackson Laboratory

Dr. Oh's main research interests focus on the human microbiome—the diverse bacteria, fungi, and viruses that inhabit our bodies—for its potential to deliver treatments for infectious and other diseases.  Dr. Oh comes to the microbiome world by way of fungal chemogenomics with technologist and geneticist Dr. Ronald Davis at Stanford and comparative genomics of wild wine yeast at the FAS Center for Systems Biology at Harvard. Prior to joining the Jackson Laboratory, she was a postdoctoral fellow at the National Human Genome Research Institute (NHGRI) of the National Institutes of Health. Dr.

Julia Oh

Assistant Professor
The Jackson Laboratory

Dr. Oh's main research interests focus on the human microbiome—the diverse bacteria, fungi, and viruses that inhabit our bodies—for its potential to deliver treatments for infectious and other diseases.  Dr. Oh comes to the microbiome world by way of fungal chemogenomics with technologist and geneticist Dr. Ronald Davis at Stanford and comparative genomics of wild wine yeast at the FAS Center for Systems Biology at Harvard. Prior to joining the Jackson Laboratory, she was a postdoctoral fellow at the National Human Genome Research Institute (NHGRI) of the National Institutes of Health. Dr.

 

Julia Straus

CEO
TULA

Julia Straus

CEO
TULA
 

Kimberly Capone

Research Fellow Lead Microbiologist for Skin Microbiome Research
Johnson & Johnson Consumer Companies

Kimberly Capone is a Research Fellow and Lead Microbiologist for Skin Microbiome Research with Johnson & Johnson Consumer Companies, Inc. in Skillman, NJ. She received her B.S. in Biology from Northeastern University in Boston, MA, proceeding to earn her Ph.D. in Microbiology and Immunology from Northwestern University in Chicago, IL. As a Research Fellow at Johnson & Johnson Consumer Companies, Inc., Dr. Capone directs investigations into the human skin microbiome in health and disease, particularly early in life and in individuals with sensitive or inflamed skin.

Kimberly Capone

Research Fellow Lead Microbiologist for Skin Microbiome Research
Johnson & Johnson Consumer Companies

Kimberly Capone is a Research Fellow and Lead Microbiologist for Skin Microbiome Research with Johnson & Johnson Consumer Companies, Inc. in Skillman, NJ. She received her B.S. in Biology from Northeastern University in Boston, MA, proceeding to earn her Ph.D. in Microbiology and Immunology from Northwestern University in Chicago, IL. As a Research Fellow at Johnson & Johnson Consumer Companies, Inc., Dr. Capone directs investigations into the human skin microbiome in health and disease, particularly early in life and in individuals with sensitive or inflamed skin.

 

Lada Rasochova

CEO
Dermala Inc.

Lada is the founder and CEO of Dermala Inc. Lada is an experienced business executive as well as scientist by training. She has been involved in commercialization of pharmaceutical and biotechnology products for the past 20 years. She spent more than 15 years in biotech and pharma industry where she held various management and leadership positions, including as the director of new business development in the Dowpharma division of the Dow Chemical Company. Prior to Dow, she was with Mycogen, a biotechnology startup that was acquired by Dow Chemical.

Lada Rasochova

CEO
Dermala Inc.

Lada is the founder and CEO of Dermala Inc. Lada is an experienced business executive as well as scientist by training. She has been involved in commercialization of pharmaceutical and biotechnology products for the past 20 years. She spent more than 15 years in biotech and pharma industry where she held various management and leadership positions, including as the director of new business development in the Dowpharma division of the Dow Chemical Company. Prior to Dow, she was with Mycogen, a biotechnology startup that was acquired by Dow Chemical.

 

Dr. Larry Weiss

MD

Larry Weiss MD, has an extensive background in natural products chemistry, microbiology, clinical medicine, and pharmaceutical development and commercialization. Dr. Weiss is board certified in Anesthesiology, has an MD from Stanford University Medical School, and a BS from Cornell University in Biochemistry. He has a number of patents and is published in the areas of chemistry, electrophysiology, and microbiology. Dr. Weiss is the founder of CleanWell Company.

Dr. Larry Weiss

MD

Larry Weiss MD, has an extensive background in natural products chemistry, microbiology, clinical medicine, and pharmaceutical development and commercialization. Dr. Weiss is board certified in Anesthesiology, has an MD from Stanford University Medical School, and a BS from Cornell University in Biochemistry. He has a number of patents and is published in the areas of chemistry, electrophysiology, and microbiology. Dr. Weiss is the founder of CleanWell Company.

 

Mark S Wilson

President & CEO
MatriSys BioScience

Mark S Wilson

President & CEO
MatriSys BioScience
 

Mingxun Wang

CEO
Ometa Labs

I am a PhD candidate at UCSD. My research interests are in bioinformatics and more specifically, I focus on computational mass spectrometry. At UCSD I have the honor of being advised by Nuno Bandeira

Prior to coming to San Diego, I attended the University of Illinois for my undergraduate degree in Computer Engineering. However, it was in Missouri that I spent my most impressionable years.

Mingxun Wang

CEO
Ometa Labs

I am a PhD candidate at UCSD. My research interests are in bioinformatics and more specifically, I focus on computational mass spectrometry. At UCSD I have the honor of being advised by Nuno Bandeira

Prior to coming to San Diego, I attended the University of Illinois for my undergraduate degree in Computer Engineering. However, it was in Missouri that I spent my most impressionable years.

 

Riëtte van Laack

Director
Hyman, Phelps, & McNamara, P.C.

Riëtte van Laack, Ph.D., provides regulatory counsel on OTC products, including foods and dietary supplements, OTC drugs, cosmetics, and animal feed and drugs on a range of FDA, USDA, FTC, and CPSC issues.

Riëtte van Laack

Director
Hyman, Phelps, & McNamara, P.C.

Riëtte van Laack, Ph.D., provides regulatory counsel on OTC products, including foods and dietary supplements, OTC drugs, cosmetics, and animal feed and drugs on a range of FDA, USDA, FTC, and CPSC issues.

 

Thomas Hitchcock

CEO & Founder
Xycrobe Therapeutics

Thomas Hitchcock is the founder and CEO of Xycrobe Therapeutics. An entrepreneur in the biotech space, Thomas has been instrumental in bringing several medical technologies successfully to the dermatological and aesthetics markets.  Thomas holds a doctorate in molecular genetics from Clemson University where he did his research on DNA damage and repair.

Thomas Hitchcock

CEO & Founder
Xycrobe Therapeutics

Thomas Hitchcock is the founder and CEO of Xycrobe Therapeutics. An entrepreneur in the biotech space, Thomas has been instrumental in bringing several medical technologies successfully to the dermatological and aesthetics markets.  Thomas holds a doctorate in molecular genetics from Clemson University where he did his research on DNA damage and repair.

 

Travis Whitfill

Co-founder and Chief Scientific Officer
Azitra Inc

Travis Whitfill is an Associate Research Scientist in the Department of Pediatrics. His background began in molecular biology and biochemistry, after receiving scientific training at the MD Anderson Cancer Center and Duke University. He is the co-founder of several additional startup companies, including a Connecticut-based microbiome company, Azitra Inc. He brings strong background in entrepreneurship and business, and is also a partner in a venture capital fund, Bios Partners, bringing experience in public markets, drug development, and venture capital investments.

Travis Whitfill

Co-founder and Chief Scientific Officer
Azitra Inc

Travis Whitfill is an Associate Research Scientist in the Department of Pediatrics. His background began in molecular biology and biochemistry, after receiving scientific training at the MD Anderson Cancer Center and Duke University. He is the co-founder of several additional startup companies, including a Connecticut-based microbiome company, Azitra Inc. He brings strong background in entrepreneurship and business, and is also a partner in a venture capital fund, Bios Partners, bringing experience in public markets, drug development, and venture capital investments.

 

Trevor Steyn

Founder
Esse Probiotic Skincare

Trevor is an organic chemist with a passion to explore new ways of treating skin and fighting ageing.

For more than 15 years his research on skin has taken a very different approach. He takes a broad, long-term perspective to anti-ageing and looks at every aspect of the skin, from its health to the external factors affecting it.

Trevor Steyn

Founder
Esse Probiotic Skincare

Trevor is an organic chemist with a passion to explore new ways of treating skin and fighting ageing.

For more than 15 years his research on skin has taken a very different approach. He takes a broad, long-term perspective to anti-ageing and looks at every aspect of the skin, from its health to the external factors affecting it.

 

Veronika Oudova

Co-founder
S-Biomedic

Veronika is a co-founder and Chief Executive Officer of S-Biomedic.

Veronika completed a master study in International Trade in Prague and a master in International Management within the program CEMS located in Prague, Vienna and Rotterdam. After her studies she has worked as project manager and marketing consultant at Cord Blood Bank Czech Republic. There she also co-founded a spin-off company StemCellPro. 

Before joining the project S-Biomedic Veronika has worked as account manager, business analyst and quality manager in the market research industry. 

Veronika Oudova

Co-founder
S-Biomedic

Veronika is a co-founder and Chief Executive Officer of S-Biomedic.

Veronika completed a master study in International Trade in Prague and a master in International Management within the program CEMS located in Prague, Vienna and Rotterdam. After her studies she has worked as project manager and marketing consultant at Cord Blood Bank Czech Republic. There she also co-founded a spin-off company StemCellPro. 

Before joining the project S-Biomedic Veronika has worked as account manager, business analyst and quality manager in the market research industry. 

 

Kit Wallen-Russell

Co-Founder, R&D and Sales Director
JooMo Ltd

Kit graduated from University College London (UCL) in 2015 with a Masters degree in Geophysics.

As a final year research project Kit investigated The friction of saline ice on aluminium, and he went on to become one of the leading experts on the topic both at UCL and probably the world. Late in 2015 he submitted a peer-reviewed scientific paper with the same name to be published in a prestigious industry journal.

Kit Wallen-Russell

Co-Founder, R&D and Sales Director
JooMo Ltd

Kit graduated from University College London (UCL) in 2015 with a Masters degree in Geophysics.

As a final year research project Kit investigated The friction of saline ice on aluminium, and he went on to become one of the leading experts on the topic both at UCL and probably the world. Late in 2015 he submitted a peer-reviewed scientific paper with the same name to be published in a prestigious industry journal.

 

Rainer Simmering

Senior Scientist, Corporate Microbiology
Henkel AG & Co, KGaA

Dr. Rainer Simmering is a Senior Scientist in the Corporate Microbiology group of Henkel AG & Co. KGaA in Düsseldorf. After finalizing his study of biology at the WWU in Muenster, he conducted a PhD at the German Institute of Human Nutrition in Potsdam, where he also stayed for another year as a Post-Doc.

In October 2000, he started at the Nestlé Research Center in Lausanne, where he was working on the detection and function of the intestinal microbiota.

Rainer Simmering

Senior Scientist, Corporate Microbiology
Henkel AG & Co, KGaA

Dr. Rainer Simmering is a Senior Scientist in the Corporate Microbiology group of Henkel AG & Co. KGaA in Düsseldorf. After finalizing his study of biology at the WWU in Muenster, he conducted a PhD at the German Institute of Human Nutrition in Potsdam, where he also stayed for another year as a Post-Doc.

In October 2000, he started at the Nestlé Research Center in Lausanne, where he was working on the detection and function of the intestinal microbiota.

 

Dr Linda M. Katz

Director, Office of Cosmetics and Colors
FDA

Dr. Linda Katz is the Director for the Office of Cosmetics and Colors (OCAC), in FDA’s Center of Foods and Applied Nutrition (CFSAN); a position that she has held since 2002, and the Interim Chief Medical Officer for CFSAN. Dr. Katz establishes the priorities and missions of OCAC focusing on cosmetic safety, compliance, certification of color additives, and research such as nanotechnology, phototoxicity and percutaneous absorption, and addresses safety and medical concerns for CFSAN regulated products. Dr.

Dr Linda M. Katz

Director, Office of Cosmetics and Colors
FDA

Dr. Linda Katz is the Director for the Office of Cosmetics and Colors (OCAC), in FDA’s Center of Foods and Applied Nutrition (CFSAN); a position that she has held since 2002, and the Interim Chief Medical Officer for CFSAN. Dr. Katz establishes the priorities and missions of OCAC focusing on cosmetic safety, compliance, certification of color additives, and research such as nanotechnology, phototoxicity and percutaneous absorption, and addresses safety and medical concerns for CFSAN regulated products. Dr.

The Agenda

We've received great feedback on other similar events...

Microbiome Invest 2017

Beauty & Money Summit 2017

Download agenda

Media Partners

Become a Sponsor or Exhibitor

Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.

With our extensive marketing experience and strategy, your partnership with the conference will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts.

CONTACT US: Ask us about the different ways you can get involved.

Contact our sponsorship team to find out more about each package by emailing [email protected] or by calling: +44 (0)20 3696 2920.

Venue

Boston,MA, USA

This year's congress is taking place in the cosmopolitan city of Boston, USA.

Boston

Conference Packages

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: discounts cannot be combined. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

Friday, February 2, 2018 to Friday, April 6, 2018
Multinational Pharma/Beauty/Personal Care
$1499
Early bird ends 6th April 2018, standard price $1799
2 day conference pass
Refreshments, breakfast & lunch
Networking opportunities
Friday, February 2, 2018 to Friday, April 6, 2018
Vendors/Service Provider
$1999
Early bird ends 6th April 2018, standard price $2299
2 day conference pass
Refreshments, breakfast & lunch
Networking opportunities
Independent beauty brands/biotech/academics (less than 10 employees)
$799
Early bird ends 6th April 2018, standard price $999
2 day conference pass
Refreshments, breakfast & lunch
Networking opportunities
Preparing registration...

Resources

Download Resource

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Contact Us